Skip to content
1 Minute Read

Clinical Research IO’s Survey Finds That Coronavirus is Disrupting Clinical Research Sites

Clinical Research IO‘s recent web survey found that COVID-19 is disrupting clinical research sites worldwide. The results are indicative of a significant slowdown in new drug development and long term effects on healthcare in general.

  • 25% of sites have stopped recruiting
  • Of the 75% that are continuing enrollment, about half (37%) are considering halting new patient enrollment
  • Sites that are still enrolling report on average, a 27% drop in recruitment

This means that aggregate recruiting is down by approximately 50% and studies will need double the time to fill enrollment. If half of the 75% stop recruiting, then clinical trial enrollment timelines will increase by four times.

Among the sites that are still conducting study visits, challenges remain.

  • Patient retention has started to fall, with an average decline of 9%,
  • The number of protocol deviations have risen, with an average increase of 4%
  • Nearly two thirds of sites (63%) have prohibited on site monitoring visits, thus inhibiting effective oversight by sponsors
  • These values are expected to increase with ongoing travel limitations and quarantines

In addition to identifying declining enrollment and retention rates, the survey revealed that over 90% of sites would utilize sponsor provided technology, meaning a direct electronic data capture tool combined with a document upload feature.

The web survey was fielded from March 19-23, 2020. A total of 73 sites across different therapeutic focuses participated.

by Maxine Lai Customer Success Manager at CRIO
Share this post
You may also find interesting
Explore our Blog
The Patient Safety Impact of Medical Record Delays in Clinical Trials
Running a Site
2 Minute Read -

The Patient Safety Impact of Medical Record Delays in Clinical Trials

In clinical trials, patient safety is paramount. Once a subject is randomized into a clinical trial, they undergo a series of treatment procedures. Any changes in their medical status, including alterations in medication or occurrence of Adverse Events (“AEs”), need to be recorded. These changes are typically noted by site staff in a document known...

Addressing the Challenge of Inaccurate and Incomplete EHRs in Clinical Research
Running a Site
2 Minute Read -

Addressing the Challenge of Inaccurate and Incomplete EHRs in Clinical Research

In our previous blog post, “Navigating Medical Records Acquisition in Clinical Trials,” we unpacked our solution for the time consuming process of sourcing patient medical records. In this followup, we’re addressing the challenge of inaccurate and incomplete EHRs in clinical research. Electronic Health Records (EHRs) form the backbone of healthcare data. However, when it comes...

Receptionist writing on medical record at front desk
Running a Site
2 Minute Read -

Navigating Medical Records Acquisition in Clinical Trials

Navigating medical records acquisition in clinical trials is a time consuming challenge faced by clinical research sites. Electronic Health Record (EHR) systems play an integral part in this process, serving as critical repositories of patient data. Yet, the lengthy process required to access these records often complicates the patient screening process. Subsequently, this impacts enrollment...